Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
15.68
-0.19 (-1.20%)
Nov 21, 2024, 2:38 PM EST - Market open
Tyra Biosciences Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$31.00
Upside
+97.70%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $32 → $30 | Strong Buy | Maintains | $32 → $30 | +91.33% | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +104.08% | Oct 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $32 | Strong Buy | Maintains | $30 → $32 | +104.08% | Oct 28, 2024 |
| Wedbush | Wedbush | Buy Reiterates $28 | Buy | Reiterates | $28 | +78.57% | Oct 25, 2024 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $22 → $31 | Hold → Strong Buy | Upgrades | $22 → $31 | +97.70% | Oct 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $30 | Strong Buy | Maintains | $25 → $30 | +91.33% | Oct 7, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $25 → $33 | Buy | Maintains | $25 → $33 | +110.46% | Sep 19, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $33 | Buy | Initiates | $33 | +110.46% | Aug 15, 2024 |
| Wedbush | Wedbush | Buy Reiterates $28 | Buy | Reiterates | $28 | +78.57% | Aug 8, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $28 → $25 | Buy | Maintains | $28 → $25 | +59.44% | Aug 8, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $28 | Buy | Reiterates | $28 | +78.57% | Jul 3, 2024 |
| Wedbush | Wedbush | Buy Reiterates $28 | Buy | Reiterates | $28 | +78.57% | Jul 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +46.68% | Jul 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +46.68% | Jun 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $25 → $28 | Buy | Reiterates | $25 → $28 | +78.57% | May 13, 2024 |
| Wedbush | Wedbush | Buy Reiterates $28 | Buy | Reiterates | $28 | +78.57% | May 10, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.